ATRX and cervical squamous cell carcinoma: We have selected the non-gastric cancer cohorts with ATRX mutation frequency more than 10%, including LGG (39.2%), UCEC (24.3%), SARC (16.9%), GBM (10.4%), CESC (10.4%), COAD (10.3%).